The agency said it believes its recent focus on the issue has tamped down on genetic testing fraud, though it expects new questionable arrangements will emerge.
The owner is accused of falsely billing Medicare for cancer genomic testing and pharmacogenetic testing that regularly exceeded $12,000 per beneficiary.
Three executives from Northwest Physicians have been indicted while an executive with Molecular Testing Labs pleaded guilty for his part in the alleged scheme.
